Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
Abstract
Citations
-
0
CrossRef
-
0
Web of Science
-
0
Scopus
Authors (20)
Cite as
Full text
full text is not available in portal
Details
- Publication year:
- 2021
- DOI:
- Digital Object Identifier (open in new tab) 10.1101/2021.01.28.21249932
- Verified by:
- No verification
seen 64 times